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Abstract
Background
We have previously found in the chronic SKGmouse model of arthritis that long standing
(5 and 8 months) inflammation directly leads to high collagen bone turnover, disorganization
of the collagen network, disturbed bonemicrostructure and degradation of bone biomechani-
cal properties. The main goal of the present work was to study the effects of the first days of
the inflammatory process on the microarchitecture and mechanical properties of bone.
Methods
Twenty eight Wistar adjuvant-induced arthritis (AIA) rats were monitored during 22 days
after disease induction for the inflammatory score, ankle perimeter and body weight.
Healthy non-arthritic rats were used as controls for compar-ison. After 22 days of disease
progression rats were sacrificed and bone samples were collected for histomorphometrical,
energy dispersive X-ray spectroscopical analysis and 3-point bending. Blood samples were
also collected for bone turnover markers.
Results
AIA rats had an increased bone turnover (as inferred from increased P1NP and CTX1,
p = 0.0010 and p = 0.0002, respectively) and this was paralleled by a decreased mineral
content (calcium p = 0.0046 and phos-phorus p = 0.0046). Histomorphometry showed
a lower trabecular thickness (p = 0.0002) and bone volume (p = 0.0003) and higher trabecu-
lar sepa-ration (p = 0.0009) in the arthritic group as compared with controls. In addition,
bone mechanical tests showed evidence of fragility as depicted by diminished values of
yield stress and ultimate fracture point (p = 0.0061 and p = 0.0279, re-spectively) in the
arthritic group.
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Conclusions
We have shown in an AIA rat model that arthritis induc-es early bone high turnover, structur-
al degradation, mineral loss and mechanical weak-ness.
Introduction
Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease, which affects
around 1% of the world-population[1]. It causes joint and systemic inflammation that is re-
flected in local and systemic bone damage[2]. Bone is a dynamic tissue composed mainly of
a type I collagen matrix that constitutes the scaffold for calcium hydroxyapatite crystal deposi-
tion. Remodelling of bone is a continuous process by which osteoclasts resorb bone tissue and
osteoblasts produce new bone matrix that is subsequently mineralised. Biochemical markers of
this bone turnover are produced and released into circulation, providing a read-out of kinetics
and the balance between bone loss and formation. More specifically, bone-resorbing osteoclasts
release carboxy-terminal collagen cross-linking telopeptides (CTX-I), a marker for bone degra-
dation, which is produced by cathepsin K that is involved in systemic bone resorption [3].
During bone formation, collagen is synthesized by osteoblasts in the form of procollagen. This
precursor contains a short signal sequence and terminal extension peptides: amino-terminal
propeptide (PINP) and carboxy-terminal propeptide. These propeptide extensions are re-
moved by specific proteinases before the collagen molecules form. PINP can be found in
the circulation and its concentration reflects the synthesis rate of collagen type I, being thus
a marker of bone formation [4]. As RA progresses there is marked articular destruction and
decreased joint mobility with radiological evidence of erosion with significant impact on life
quality within 2 years of disease onset [5]. In addition, osteoporosis is a common finding in
patients with RA [6] and is responsible for increased rates of vertebral and hip fractures in
these patients [7, 8]. RA is associated with an increased expression of the receptor activator of
RANKL (receptor activator of nuclear factor kappa–B ligand, NF-KB ligand) and low levels of
its antagonist, osteoprotegerin (OPG) [9]. In addition, very early on in the disease process,
RA serum and synovial fluid present a cytokine profile, including interleukin (IL) 1, IL6, IL17
and tumour necrosis factor (TNF), which further favours osteoclast differentiation and activa-
tion[10–12]. Evidence suggests that bone remodelling disturbances in RA contribute not only
to local bone erosions but also to the development of systemic osteoporosis [13].
We have previously found in a chronic animal model of arthritis (SKG mouse model) that
prolonged inflammation (5 and 8 months) directly leads to the degradation of bone bio-
mechanical properties, namely stiffness, ductility and bone strength, which was paralleled by
a high collagen bone turnover and disorganization[4, 12, 14, 15]. Based on the fact that most
of the effectors of bone metabolism are engaged in the disease process since the early phase, we
now hypothesise that this process starts upon the first inflammatory manifestations[10–12].
To test this we selected the adjuvant-induced arthritis (AIA) model in rats, characterized
by a rapid onset polyarticular inflammation and widely used for testing new treatments for
arthritis [16–18]. Understanding the systemic inflammatory consequences on bone would
expand the use of this model also for testing new drugs with potential bone therapeutic effects.
The main goal of the present work was to study, in a rat model of AIA, the effects of the first
days of the systemic inflammatory process on the microarchitecture and mechanical properties
of bone.
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Materials and Methods
Animal experimental design
Twenty-eight Wistar AIA rats were purchased from Charles River Laboratories International
(Massachusetts, USA). Eight-week-old females weighing 200–230 g were maintained under
specific pathogen free (SPF) conditions. All experiments were approved by the Animal User
and Ethical Committees of the Instituto de Medicina Molecular, Lisbon University, according
to the Portuguese law and the European recommendations. Animals were sacrificed when pre-
senting an inflammatory score (0–3) of 3 in 2 paws or when presenting 20% of body
weight loss.
Rats were housed per groups (healthy vs arthritic) under standard laboratory conditions
(at 22°C under 12-hour light/12-hour dark conditions). The inflammatory score, ankle
perimeter and body weight were measured during the study period. Inflammatory signs were
evaluated by counting the score of each joint in a scale of 0–3 (0— absence; 1— erythema;
2— erythema and swelling; 3— deformities and functional impairment). The total score of
each animal was defined as the sum of the partial scores of each affected joint [19]. Rats were
sacrificed by CO2narcosis after 22 days of disease evolution and blood as well as bone samples
were collected.
Bone remodelling markers quantification
Serum samples were collected at the time of sacrifice and stored at -80°C. Bone remodelling
markers CTX I (C-terminal telopeptides of type-I collagen) and P1NP (total procollagen type
1 N-terminal propeptide) were quantified by Serum Rat-Laps ELISA assay (Immunodiagnostic
Systems Ltd, Boldon, UK), according to the provider’s instructions.
Bone histomorphometry
The 4th lumbar vertebrae (L4) were collected from each animal at sacrifice for histomorpho-
metric analysis. Samples were fixed immediately in ethanol 70% and then dehydrated with
increasing ethanol concentrations (96% and 100%). Samples were next embedded in methylme-
tacrylate (MMA) solution. Serial transversal sections through L4 were performed with 5-μm-
thick and stained with Aniline Blue in order to distinguish bone and bone marrow, allowing
bone structural analysis. Images were acquired using a Leica DM2500 microscope equipped with
a colour camera Leica CCD Camera (Leica microsystems, Wetzlar, Germany)[20].
All variables were expressed and calculated according to the recommendations of the American
Society for Bone andMineral Research [21], using a morphometric program (Image J 1.46R with
plugin Bone J).
Ratio of trabecular bone volume / total tissue volume, trabecular thickness and trabecular
separation were evaluated by standard histomorphometric parameters at x12.5 magnification.
Energy dispersive X-ray spectroscopy analysis
Energy dispersive X-ray spectroscopy is a sensitive qualitative and semi-quantitative technique
to evaluate the mineral content in bone. The quantitative information is based on the relative
elemental abundance.
Using a standard system, semi-quantitative X-ray fluorescence measurements were
performed in cortical and trabecular bone powder samples, with the purpose of quantifying
calcium and phosphorus concentration.
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After excision, fresh femurs were freeze dried for 46 hours, with a multipurpose ice condenser
(ModulyoD-230, Thermo Savant, Schwerte, Germany) operated at a nominal temperature of
-50°C, in order to remove excess of water.
The semi-quantitative measurements of bone powder were performed with a 4 kW com-
mercial wavelength dispersive X-ray fluorescence spectrometer (Bruker S4 Pioneer, Karlsruhe,
Germany), using a Rh X-ray tube with a 75 mm Be end window and a 34 mm diameter colli-
mator mask. Measurements were performed in helium mode and using high-density polyethyl-
ene X-ray fluorescence sample cups with 35.8 mm diameter assembled with a 4 mm prolene
film to support the bone sample. The polyethylene cup was placed in steel sample cup holders
with an opening diameter of 34 mm.
Bone mechanical testing
Bone mechanical properties were evaluated by a three-point bending method using a electro-
mechanical machine (model 5566, Instron Corporation, Canton, USA) using a load-cell of
500N. The femur was placed on a holding device with a support span distance of 5 mm (L),
with the lesser trochanter proximal in contact with the proximal transverse bar. The load was
applied at the mid-shaft of the diaphysis with a cross-head speed of 0.005 mm/s until the
fracture occurred.
The stress-strain curve can be obtained from the load-displacement representation, with the
initial dimensions of the sample, using engineering equations (S1B Fig.).
An example of a stress-strain curve obtained in the three point bending tests is shown in
S1A Fig. The points of the yield stress and ultimate stress are indicated. This stress-strain curve
can be broken down into pre-yield and post-yield portions. Pre-yield toughness represents the
area under the stress/strain curve up to the yield point, which is where permanent deformation
of the bone has occurred while post-yield toughness represents the area under the curve be-
tween the yield point and bone fracture. In these bending tests there is a significant amount of
displacement between the yield point and the eventual fracture[22].
Statistical analysis
Continuous variables were expressed by mean +- standard deviation (SD) or median and
interquartile range. The normality distribution was assessed by D’Agostino and Pearson test.
Statistical differences were determined with parametric t–test or non-parametric Mann Whit-
ney test according variables distribution using GraphPad Prism (GraphPad, California, USA).
Differences were considered statistically significant for p values 0.05.
Results
Inflammatory progress
First, we validated the kinetic of disease development of the AIA rat model. Inflammatory
signs (Fig. 1A) and ankle perimeter (Fig. 1B) were assessed throughout time, as shown in
Fig. 1. All animals from the arthritic group (N = 16) presented arthritis signs by the fourth day
post disease induction.
Statistical differences were determined with non-parametric MannWhitney test using
GraphPad Prism (GraphPad, California, USA). Differences were considered statistically signifi-
cant for p values 0.05.
The initial acute inflammation was observed around day 4 and progressed during 22 days
post disease induction. After 10 days of arthritis induction, the inflammatory manifestations
increased sharply as depicted by an increase in ankle perimeter. Maximal swelling occurred at
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day 19 post disease induction. At day 22 post arthritis induction inflammatory score (Fig. 1C)
and ankle perimeter (Fig. 1D) were significantly increased in the arthritic group (p = 0.0037
and p = 0.0085, respectively) in comparison with healthy control rats.
Bone turnover markers
Bone resorption marker CTX I, which reflects osteoclastic activity, is a degradation product of
type I collagen, the major structural protein of bone. While the bone formation marker P1NP,
a bio product of type I collagen synthesis, is a marker for osteoblastic activity.
We have observed that both CTXI (Fig. 2A) and P1NP (Fig. 2B) were significantly
increased in the arthritic group in comparison with the healthy control animals (p = 0.0002
and p = 0.0010, respectively), revealing an increase of bone turnover in the arthritic group.
Figure 1. Inflammatory score (A) and ankle perimeter (B) throughout time. Inflammatory score (C) (p = 0.0037) and Ankle perimeter (D) (p = 0.0085) in
control (N = 12) and arthritic groups (N = 16) by the time of sacrifice after 22 days post disease induction.
doi:10.1371/journal.pone.0117100.g001
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Histomorphometry of bone
Bone histomorphometry was used to measure bone static parameters such as bone trabecular
volume, trabecular thickness and trabecular separation in order to determine the effects of in-
flammation on bone microstructure (Fig. 3A).
Trabecular bone volume (p = 0.0003) (Fig. 3B) and trabecular thickness (p = 0.0002)
(Fig. 3C) were significantly reduced in arthritic animals comparing with healthy control ani-
mals. Moreover, trabecular separation (p = 0.0009) (Fig. 3D) was significantly increased in the
arthritic group, in comparison with healthy control rats.
Energy dispersive X-ray spectroscopy
Calcium (Ca) and Phosphorus (P) are the most abundant elements present in bone mineral
matrix. In fact, calcium has been reported as the most important nutrient associated with peak
bone mass and may be the only one for which there is epidemiological evidence of a relation to
fracture rate[23].
We used energy dispersive X-ray spectroscopy to quantify the calcium and phosphorus con-
tent in our samples. We have observed that Ca (p = 0.0046) (Fig. 4A) and P (p = 0.0046)
(Fig. 4B) content were decreased in the arthritic group as compared to controls.
Bone mechanics
The three-point-bending biomechanical tests aimed to explore the bone mechanical compe-
tence of both groups 22 days post disease induction. Results showed decreased values of yield
stress (moment of occurrence of first micro fractures) (p = 0.0061) (Fig. 5A) and ultimate stress
(moment of occurrence of complete fracture) (p = 0.0279) (Fig. 5B) in arthritic animals when
compared to the control group.
Discussion
In the present study, we demonstrated in an AIA rat model, that arthritis induces very early
high bone turnover, trabecular degradation, mineral loss and mechanical weakness.
Figure 2. Bone turnover markers quantification in control (N = 9) and arthritic rats (N = 13). Serum samples collected at day 22 (sacrificed) were
analysed by ELISA technique. Bone resorption marker, CTX I (A) and bone formation marker, P1NP (B) were increased in arthritic rats (p = 0.0002 and
p = 0.0010, respectively).
doi:10.1371/journal.pone.0117100.g002
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Figure 3. Bone histomorphometry assessment of the 4th lumbar vertebra (L4). Assessment of L4 in control (N = 12) and arthritic group (N = 16).
(A) Illustrative Aniline blue stained sections of L4 vertebra collected at day 22 post disease induction (sacrifice). Bone volume per tissue volume or trabecular
bone volume fraction (B) and trabecular thickness (C) were decreased in arthritic rats while trabecular separation (D) was increased. Magnification x12.5.
doi:10.1371/journal.pone.0117100.g003
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Biochemical markers of bone turnover were quantified in order to evaluate the impact of
systemic inflammation on bone metabolism. An increased bone turnover activity was shown in
arthritic animals, as depicted by increased CTXI and P1NP levels. This observation was consis-
tent with previously published data showing the presence of a large number of osteoclasts in
AIA bone [17]. Data already published by our group in another animal model of arthritis
(the SKGmice model) have also shown that P1NP levels were increased in arthritic animals
and so did CTX-I levels [4], reflecting an overall increase in bone turnover [24]. Studies on
RA patients measuring P1NP have produced varying results, whereas measurements in CTX-I
mostly show increased levels [25]. In RA patients bone metabolism is more active (increased
P1NP) in earlier stages of the disease and a decrease in bone metabolic activity (both P1NP and
CTX) occurs with disease progression, both showing correlation with tender and swollen joints
[15]. Despite the existing variability, P1NP has been mainly found to be increased in RA patients
Figure 4. Calcium and Phosphorus bone content acquired by energy dispersive X-ray spectroscopy. Ca (A) and P (B) bone content were decreased
in the arthritic group (N = 16) as compared with controls (N = 12). Bone powder was acquired from bone samples collected at day 22 post disease induction
(sacrifice).
doi:10.1371/journal.pone.0117100.g004
Figure 5. Mechanical analysis acquired by 3 point bending tests. Yield stress (A) and Ultimate stress (B) were decreased in arthritic rats (N = 16) as
compared to controls (N = 12). Bone samples were collected at day 22 post disease induction (sacrifice).
doi:10.1371/journal.pone.0117100.g005
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when compared to controls, together with CTX-I, revealing a compensatory mechanism in bone
turnover [26].
Due to increased bone turnover it was therefore of interest to assess the effects of inflamma-
tion on bone microstructure. Histomorphometric data revealed, in arthritic animals, a lower
fraction of trabecular bone volume and a lower average trabecular thickness as well as a higher
average trabecular separation, in comparison with controls. These findings were in line with
the described bone volume loss, measured by uCT, in this rat model [17].
In addition, we quantified calcium and phosphorus content, the two major minerals present
in bone [27], by energy dispersive X-ray spectroscopy. The arthritic group showed a significant
decreased mineral content, when compared to the control group. This result corroborated an
overall bone mineral loss, as a result of an unbalanced high bone turnover, which might lead to
bone fragility and consequently fracture.
In accordance, mechanical tests revealed that arthritic femurs have a significantly lower
yield stress and ultimate stress as compared to control femurs, meaning that bone is more frag-
ile and prone to fracture.
In summary, we have shown, in an AIA rat model, that the systemic inflammation associat-
ed with a polyarthritis is able to induce an early high bone turnover, bone microarchitecture
degradation, low mineral content and mechanical weakness. In addition, our results have
expanded the knowledge on this model. In fact, our findings, suggest that AIA is a fast and
adequate model to study the effects of arthritis on bone properties and consequently a poten-
tially accurate model to study anti-arthritic compounds with bone protective effects.
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